BurneyRGiudiceL. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–519.
2.
SimoensSDunselmanGDirksenC. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012;27(5):1292–1299.
3.
VercelliniPBarbaraGAbbiatiASomiglianaEViganoPFedeleL. Repetitive surgery for recurrent symptomatic endometriosis: what to do?Eur J Obstet Gynecol Reprod Biol. 2009;146(1):15–21.
4.
TaskinMGungorAAdaliEYayAOnderGIncebozU. A humanized anti-interleukin 6 receptor monoclonal antibody, tocilizumab, for the treatment of endometriosis in a rat model. Reprod Sci. 2016;23(5):662–669.
5.
TostiCPinzautiSSantulliPChapronCPetragliaF. Pathogenetic mechanisms of deep infiltrating endometriosis. Reprod Sci. 2015; 22(9):1053–1059.
6.
LeconteMSantulliPChouzenouxS. Inhibition of MAPK and VEGFR by sorafenib controls the progression of endometriosis. Reprod Sci. 2015;22(9):1171–1180.
ZanattaAPereiraRRochaA. The relationship among HOXA10, estrogen receptor α, progesterone receptor, and progesterone receptor B proteins in rectosigmoid endometriosis: a tissue microarray study. Reprod Sci. 2015;22(1):31–37.
9.
VitaglianoANoventaMQuarantaMGizzoS. Statins as targeted “magical pills” for the conservative treatment of endometriosis: may potential adverse effects on female fertility represent the “dark side of the same coin”? A systematic review of literature. Reprod Sci. 2016;23(4):415–428.
10.
RogersPAdamsonGAl-JefoutM. Research priorities for endometriosis: recommendations from a Global Consortium of Investigators in Endometriosis. Reprod Sci. 2017;24(2):275–299.
11.
RogersPD’HoogheTFazleabasA. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009;16(4):335–346.
12.
RogersPD’HoogheTFazleabasA. Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis in Montpellier, France. Reprod Sci. 2013;20(5):483–499.
